427 related articles for article (PubMed ID: 29862509)
41. Expression of hepatitis B virus X protein is closely correlated with the high periportal inflammatory activity of liver diseases.
Jin YM; Yun C; Park C; Wang HJ; Cho H
J Viral Hepat; 2001 Sep; 8(5):322-30. PubMed ID: 11555189
[TBL] [Abstract][Full Text] [Related]
42. IFNgamma expression inhibits LHBs storage disease and ground glass hepatocyte appearance, but exacerbates inflammation and apoptosis in HBV surface protein-accumulating transgenic livers.
Reifenberg K; Hildt E; Lecher B; Wiese E; Nusser P; Ott S; Yamamura K; Rutter G; Löhler J
Liver Int; 2006 Oct; 26(8):986-93. PubMed ID: 16953839
[TBL] [Abstract][Full Text] [Related]
43. Proteins ZNF198 and SUZ12 are down-regulated in hepatitis B virus (HBV) X protein-mediated hepatocyte transformation and in HBV replication.
Wang WH; Studach LL; Andrisani OM
Hepatology; 2011 Apr; 53(4):1137-47. PubMed ID: 21480320
[TBL] [Abstract][Full Text] [Related]
44. Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinoma.
Safaie P; Poongkunran M; Kuang PP; Javaid A; Jacobs C; Pohlmann R; Nasser I; Lau DT
World J Gastroenterol; 2016 Mar; 22(12):3404-11. PubMed ID: 27022222
[TBL] [Abstract][Full Text] [Related]
45. CRISPR/Cas9-mediated knockout of HBsAg inhibits proliferation and tumorigenicity of HBV-positive hepatocellular carcinoma cells.
Song J; Zhang X; Ge Q; Yuan C; Chu L; Liang HF; Liao Z; Liu Q; Zhang Z; Zhang B
J Cell Biochem; 2018 Nov; 119(10):8419-8431. PubMed ID: 29904948
[TBL] [Abstract][Full Text] [Related]
46. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
47. Chronic Hepatitis B Virus Infection: The Relation between Hepatitis B Antigen Expression, Telomere Length, Senescence, Inflammation and Fibrosis.
Tachtatzis PM; Marshall A; Arvinthan A; Verma S; Penrhyn-Lowe S; Mela M; Scarpini C; Davies SE; Coleman N; Alexander GJ
PLoS One; 2015; 10(5):e0127511. PubMed ID: 26024529
[TBL] [Abstract][Full Text] [Related]
48. The transcription factor c-JUN/AP-1 promotes HBV-related liver tumorigenesis in mice.
Trierweiler C; Hockenjos B; Zatloukal K; Thimme R; Blum HE; Wagner EF; Hasselblatt P
Cell Death Differ; 2016 Apr; 23(4):576-82. PubMed ID: 26470729
[TBL] [Abstract][Full Text] [Related]
49. Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells.
Eyre NS; Phillips RJ; Bowden S; Yip E; Dewar B; Locarnini SA; Beard MR
J Hepatol; 2009 Sep; 51(3):446-57. PubMed ID: 19596477
[TBL] [Abstract][Full Text] [Related]
50. [Chronic hepatitis B virus infection and the methylation status of p16INK4A promoter].
Zhu R; Li BZ; Ling YQ; Zhang HP; Li H; Liu Y; Hu XQ; Zhu HG
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):166-70. PubMed ID: 17649629
[TBL] [Abstract][Full Text] [Related]
51. Promoting effect of hepatitis B virus on the expressoin of phospholipase A2 group IIA.
Zhu C; Song H; Shen B; Wu L; Liu F; Liu X
Lipids Health Dis; 2017 Jan; 16(1):5. PubMed ID: 28077172
[TBL] [Abstract][Full Text] [Related]
52. Anti-HBV drugs suppress the growth of HBV-related hepatoma cells via down-regulation of hepatitis B virus X protein.
Zhang S; Gao S; Zhao M; Liu Y; Bu Y; Jiang Q; Zhao Q; Ye L; Zhang X
Cancer Lett; 2017 Apr; 392():94-104. PubMed ID: 28192212
[TBL] [Abstract][Full Text] [Related]
53. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma.
Hong B; Qian Y; Zhang H; Sang YW; Cheng LF; Wang Q; Gao S; Zheng M; Yao HP
World J Gastroenterol; 2016 May; 22(18):4538-46. PubMed ID: 27182163
[TBL] [Abstract][Full Text] [Related]
54. Possible Involvement of Multidrug-Resistant Hepatitis B Virus sW172* Truncation Variant in the ER Stress Signaling Pathway during Hepatocarcinogenesis.
Zheng J; Jiang S; Lu F
Jpn J Infect Dis; 2016 Jul; 69(4):306-13. PubMed ID: 26567840
[TBL] [Abstract][Full Text] [Related]
55. Clinical Implications of HBV PreS/S Mutations and the Effects of PreS2 Deletion on Mitochondria, Liver Fibrosis, and Cancer Development.
Liang YJ; Teng W; Chen CL; Sun CP; Teng RD; Huang YH; Liang KH; Chen YW; Lin CC; Su CW; Tao MH; Wu JC
Hepatology; 2021 Aug; 74(2):641-655. PubMed ID: 33675094
[TBL] [Abstract][Full Text] [Related]
56. Association of the Hepatitis B Virus Large Surface Protein with Viral Infectivity and Endoplasmic Reticulum Stress-mediated Liver Carcinogenesis.
Lin WL; Hung JH; Huang W
Cells; 2020 Sep; 9(9):. PubMed ID: 32911838
[TBL] [Abstract][Full Text] [Related]
57. Hepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseases.
Lamontagne J; Steel LF; Bouchard MJ
World J Gastroenterol; 2015 Jun; 21(24):7375-99. PubMed ID: 26139985
[TBL] [Abstract][Full Text] [Related]
58. Hepatitis B virus pre-S2 mutant upregulates cyclin A expression and induces nodular proliferation of hepatocytes.
Wang HC; Chang WT; Chang WW; Wu HC; Huang W; Lei HY; Lai MD; Fausto N; Su IJ
Hepatology; 2005 Apr; 41(4):761-70. PubMed ID: 15726643
[TBL] [Abstract][Full Text] [Related]
59. Aberrant cyclin A expression and centrosome overduplication induced by hepatitis B virus pre-S2 mutants and its implication in hepatocarcinogenesis.
Wang LH; Huang W; Lai MD; Su IJ
Carcinogenesis; 2012 Feb; 33(2):466-72. PubMed ID: 22159224
[TBL] [Abstract][Full Text] [Related]
60. HBsAg expression of liver correlates with histological activities and viral replication in chronic hepatitis B.
Cheng PN; Chiu YC; Tsai HW; Wang RH; Chiu HC; Wu IC; Chang TT
Ann Hepatol; 2014; 13(6):771-80. PubMed ID: 25332263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]